Tackling the Serious Global
Challenges in Infectious Disease

Appili was created to deliver innovative drug development programs for unmet patient needs across a broad spectrum of infectious diseases 

ACCELERATING drug development

Advancing DRUG DEVELOPMENT IN infectious disease AND BIODEFENSE to provide solutions to patients, doctors, and society

experienceD Leadership team

Leadership team skilled in advancing programs with upside potential

partnering with Appili

Active partnering and in-licensing efforts to expand clinical programs and accelerate commercialization

Innovation Across a Broad Spectrum of Anti-Infectives


Potential first in-class vaccine  candidate tackling a serious bioterrorism


A novel topical antiparasitic product to treat disfiguring infections around the world


Liquid oral reformulation of metronidazole for the growing number of patients who are unable to take the current tablet treatment